Bank Vontobel AG Share Price

Certificat

RMBIPV

CH1293290032

Delayed Swiss Exchange 16:20:00 14/03/2024 GMT
101 CHF +0.10% Intraday chart for Bank Vontobel AG
3 months+2.85%
Current year+2.54%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMBIPV
ISINCH1293290032
Date issued 22/09/2023
Strike 249.7 CHF
Maturity 22/09/2025 (474 Days)
Parity 0.25 : 1
Emission price 99 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101 CHF
Lowest since issue 96.7 CHF

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
234.2 CHF
Average target price
277.5 CHF
Spread / Average Target
+18.50%
Consensus
  1. Stock Market
  2. Certificates
  3. RMBIPV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW